HT
Herriot Tabuteau
Chief Executive Officer

Herriot Tabuteau insider trades: Axsome Therapeutics (AXSM) stock sales

Chief Executive Officer, Axsome Therapeutics Last trade Aug 6, 2026 22 Form 4 filings
$76.0M
Sold, last 12 months
6 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Herriot reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 6, 2026AXSM↓ Sell$10.5M
Jul 1, 2026AXSM↓ Sell$11.9M
Jun 9, 2026AXSM↓ Sell$12.0M
Feb 2, 2026AXSM↓ Sell$6.0M
Jan 7, 2026AXSM↓ Sell$23.9M
Dec 4, 2025AXSM↓ Sell$11.6M
Nov 5, 2025AXSM↓ Sell$21.8M
Oct 8, 2025AXSM↓ Sell$5.4M
Sep 16, 2025AXSM↓ Sell$7.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AXSM insiders

Open-market trades in the last 12 months

About Herriot Tabuteau's insider trades

Herriot Tabuteau is Chief Executive Officer at Axsome Therapeutics (AXSM). Since Sep 16, 2025, Herriot has reported no open-market purchases and 9 sales worth $110.6M on SEC Form 4. In the last 12 months: 6 sales ($76.0M).

Their filings also include grants and awards (13 filings), option exercises (9 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXSM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.